Metronidazole USP from Japan
Metronidazole is a synthetic nitroimidazole derivative classified as a drug under HTS 2933.29.4500 due to its unfused imidazole ring structure and primary use as an antibiotic. It treats anaerobic bacterial infections, protozoal infections like trichomoniasis, and certain gastrointestinal conditions.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA Drug Master File (DMF) and ensure compliance with USP standards for purity and impurities
• Provide Certificate of Analysis (CoA) and stability data; common pitfall is inadequate microbial testing documentation
• Verify bulk API status vs finished dosage forms to avoid misclassification under Chapter 30